SCHEMBL1647148

SCHEMBL1647148

O=C(C=Cc1cc(O)ccc1Br)CC(=O)C=Cc1cc(O)ccc1Br

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 14/20 0.85
APP P05067 2/20 0.55
AKR1B10 O60218 1/20 0.52
AKR1B1 P15121 1/20 0.52
MAOB P27338 1/20 0.52
PTGS2 P35354 1/20 0.52
GLO1 Q04760 1/20 0.52
CAMK2A Q9UQM7 1/20 0.52
MAPT P10636 3/20 0.48
ALOX5 P09917 1/20 0.48
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
CYP2C19 P33261 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1647145 1.00 BACE1 (0.85) BACE1APPAKR1B10AKR1B1MAOB
SCHEMBL1648591 0.92 BACE1 (1.00) BACE1AKR1B10AKR1B1MAOBPTGS2
SCHEMBL1646656 0.92 BACE1 (0.74) BACE1APPAKR1B10AKR1B1MAOB
SCHEMBL1648589 0.92 BACE1 (1.00) BACE1AKR1B10AKR1B1MAOBPTGS2
SCHEMBL1646655 0.92 BACE1 (0.74) BACE1APPAKR1B10AKR1B1MAOB
SCHEMBL1645401 0.87 BACE1 (0.84) BACE1APPAKR1B1MAOBMAPT
SCHEMBL1645403 0.87 BACE1 (0.84) BACE1APPAKR1B1MAOBMAPT
SCHEMBL1647560 0.86 APP (0.82) BACE1APPAKR1B10AKR1B1MAPT
SCHEMBL1647106 0.86 BACE1 (0.74) BACE1APPMAPTALOX5MEN1
SCHEMBL1647558 0.86 APP (0.82) BACE1APPAKR1B10AKR1B1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8552220-B2 Therapeutic agent for Alzheimer's disease TOKYO INSTITUTE OF TECHNOLOGY (JP) 2013-10-08 US disclosed
EP-2305629-A1 THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE Tokyo Institute of Technology (JP) 2011-04-06 EP disclosed